How to valuate and make your project out? What are the best options among licensing, corporating or creating a start-up? On which grounds are TTOs advising to create a spin-off rather than out-licensing the IP or a contract-based R&D collaboration? What each of these alternatives entail? What kind of surroundings would you need for each of these options?

Speakers
Tony Hickson - Cancer Research UK
Laetitia Szaller - AM Pharma
Jason Mellad - Start Codon
Bobby Soni - BioInnovation Institute
Lisa Urquhart - Evaluate Vantage
Jérôme Van Biervliet - VIB

Continue your tour